CELLECTAR BIOSCIENCES, INC.

Analyst Reco. Cellectar Biosciences, Inc.

Equities

CLRB

US15117F8077

Market Closed - Nasdaq Other stock markets 21:00:00 15/05/2024 BST			5-day change	1st Jan Change
3.36 ^USD	+5.66%		+5.00%	+21.30%

05-14	Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024
05-14	Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Roth MKM Raises Cellectar Biosciences' Price Target to $28 From $20, Retains Buy Rating	03-28	MT
Oppenheimer Adjusts Cellectar Biosciences Price Target to $12 From $11, Maintains Outperform Rating	03-28	MT
Oppenheimer Boosts Price Target on Cellectar Biosciences to $11 From $8, Maintains Outperform Rating	01-09	MT
Investors lower their expectations	01-08
Oppenheimer Cuts Cellectar Biosciences Price Target to $8 From $10, Maintains Outperform Rating	11/09/23	MT
Oppenheimer Adjusts Cellectar Biosciences Price Target to $10 From $11, Maintains Outperform Rating	05/05/23	MT
HC Wainwright Adjusts Price Target on Cellectar Biosciences to $4 From $30, Maintains Buy Rating	04/11/22	MT
Oppenheimer Adjusts Cellectar Biosciences Price Target to $12 From $47, Maintains Outperform Rating	04/11/22	MT
Oppenheimer Adjusts Cellectar Biosciences Price Target to $47 From $5.50, Maintains Outperform Rating	08/08/22	MT
Maxim Group Adjusts Cellectar Biosciences Price Target to $2 From $3, Maintains Buy Rating	02/02/22	MT
Cellectar Biosciences : Says Data From Trial Show 16.7% Complete Response Rate in Rare Blood Cancer Patients; Shares Down	04/06/21	MT
CELLECTAR BIOSCIENCES : Oppenheimer Adjusts Cellectar Biosciences' Price Target to $5.50 From $5, Maintains Outperform Rating	28/12/20	MT
Cellectar Biosciences, Inc. Reports Positive Top-Line Response Rate of 30% from R/R Multiple Myeloma Cohort in Ongoing Phase 2 Study of Clr 131	25/02/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer